Posterior fossa ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes (Part I of ependymomas across compartments) - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Ependymomas in the Posterior Fossa: An In-Depth Analysis of Molecular Classification, Treatment Protocols, and Clinical Outcomes (Part I on Ependymomas in Various Locations)

  • By

  • George W. Koutsouras

  • Francisco Rivera

  • Anthony M. Price

  • Derek S. Tsang

  • Adam Esbenshade

  • Vijay Ramaswamy

  • Peter B. Dirks

  • Michael C. Dewan

  • September 22, 2026

Share

Objective:

To synthesize current evidence regarding the biology, imaging, management, recurrence, and molecular stratification of posterior fossa ependymomas (PFE).

Approach:
  • Surgical Management: Surgical treatment is central to PFE management, with gross total resection (GTR) being the primary goal to improve patient outcomes.
Key Findings:
  • PFA tumors are linked to poorer clinical outcomes and are more common in younger children.
  • PFB tumors generally present in adolescents and adults and have a less aggressive clinical course.
  • Molecular subgrouping influences disease management and prognostic information.
  • GTR is associated with improved survival outcomes compared to subtotal resection (STR).
Interpretation:

Molecular classification provides critical insights into the biological behavior of posterior fossa ependymomas, influencing treatment strategies and clinical outcomes.

Limitations:
  • The review does not provide comprehensive data on all treatment protocols for PFE.
  • Individual patient factors influencing outcomes are not fully addressed.
Conclusion:

Molecular stratification is essential for understanding prognosis and tailoring management strategies for posterior fossa ependymomas.

Sources:

Original Source(s)

Related Content